Article Text

Novel diagnostic procedure
Coronary thrombosis: In vivo, ex vivo and in vitro
  1. Diana A Gorog1,
  2. Smriti Saraf2,
  3. Vias Markides3
  1. 1
    East & North Hertfordshire NHS Trust, Cardiology, Queen Elizabeth II Hospital, Welwyn Garden City AL7 4HQ, UK
  2. 2
    East and North Hertfordshire NHS Trust, Cardiology, Howlands, Welwyn Garden City AL7 4HQ, UK
  3. 3
    Royal Brompton and Harefield NHS Trust, Cardiology, Sydney Street, London SW3 6NP, UK
  1. Diana A Gorog, d.gorog{at}imperial.ac.uk

Summary

Acute stent thrombosis remains one of the most important concerns in clinical cardiology. The mechanism is not fully understood but a prothrombotic state is a key component. We describe a case of acute stent thrombosis, within an hour of rescue angioplasty, despite use of full dose fibrinolytic (reteplase) and antiplatelet therapy (aspirin and clopidogrel). Risk of acute stent thrombosis was predicted an hour earlier, when the patient was clinically well, by a novel near-patient test of thrombotic and thrombolytic status (in vitro). Subsequent stent thrombosis was visualised angiographically (in vivo) and confirmed by extraction of the thrombus (ex vivo). The near-patient test sensitively detected reversal of the prothrombotic state after abciximab treatment. We believe this is the first description of the clinical use of a near-patient test within the cardiac catheterisation laboratory to predict risk of imminent stent thrombosis.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.